Back
Spero Therapeutics Vs. CytomX Therapeutics Industry Stock Comparison
Sell
13
SPRO
Spero Therapeutics
Last Price:
1.13
Seasonality Move:
7.16%
Sell
46
CTMX
CytomX Therapeutics
Last Price:
1.02
Seasonality Move:
13.92%
Sell
13
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy, Sell or Hold?
- The current Spero Therapeutics [SPRO] share price is $1.13. The Score for SPRO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- SPRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy, Sell or Hold?
- The current CytomX Therapeutics [CTMX] share price is $1.02. The Score for CTMX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- CTMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRO Stock Price Chart
What is Spero Therapeutics's stock price today?
-
The Spero Therapeutics share price today is $1.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing slight selling pressure.
CTMX Stock Price Chart
What is CytomX Therapeutics's stock price today?
-
The CytomX Therapeutics share price today is $1.02
The current trend is relatively stagnant and CTMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 35.13 | Sell |
Chaikin Money Flow: | -27946 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.32) | Sell |
Bollinger Bands (100): | (1.24 - 1.38) | Sell |
CTMX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 52.62 | Buy |
Chaikin Money Flow: | 657223 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.92 - 1.06) | Buy |
Bollinger Bands (100): | (1.03 - 1.33) | Sell |
SPRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Sell |
20-day SMA: | 1.24 | Sell |
50-day SMA: | 1.27 | Sell |
200-day SMA: | 1.43 | Sell |
8-day EMA: | 1.18 | Sell |
20-day EMA: | 1.22 | Sell |
50-day EMA: | 1.26 | Sell |
200-day EMA: | 1.37 | Sell |
CTMX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.91 | Buy |
20-day SMA: | 0.97 | Buy |
50-day SMA: | 1.07 | Sell |
200-day SMA: | 1.58 | Sell |
8-day EMA: | 0.94 | Buy |
20-day EMA: | 0.97 | Buy |
50-day EMA: | 1.06 | Sell |
200-day EMA: | 1.38 | Sell |
Spero Therapeutics Earnings Growth & SPRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.
CytomX Therapeutics Earnings Growth & CTMX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.
Spero Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CytomX Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |